1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice.
Abstract
The involvement of radiofrequency electromagnetic fields (RF-EMF) in the neurodegenerative disease, especially Alzheimer's disease (AD), has received wide consideration, however, outcomes from several researches have not shown consistency. In this study, we determined whether RF-EMF influenced AD pathology in vivo using Tg-5xFAD mice as a model of AD-like amyloid β (Aβ) pathology. The transgenic (Tg)-5xFAD and wild type (WT) mice were chronically exposed to RF-EMF for 8 months (1950 MHz, SAR 5W/kg, 2 hrs/day, 5 days/week). Notably, chronic RFEMF exposure significantly reduced not only Aβ plaques, APP, and APP carboxyl-terminal fragments (CTFs) in whole brain including hippocampus and entorhinal cortex but also the ratio of Aβ42 and Aβ40 peptide in the hippocampus of Tg-5xFAD mice. We also found that parenchymal expression of β-amyloid precursor protein cleaving enzyme 1(BACE1) and neuroinflammation were inhibited by RF-EMF exposure in Tg-5xFAD. In addition, RF-EMF was shown to rescue memory impairment in Tg-5xFAD. Moreover, gene profiling from microarray data using hippocampus of WT and Tg- 5xFAD following RF-EMF exposure revealed that 5 genes (Tshz2, Gm12695, St3gal1, Isx and Tll1), which are involved in Aβ, are significantly altered inTg-5xFAD mice, exhibiting different responses to RF-EMF in WT or Tg-5xFAD mice; RF-EMF exposure in WT mice showed similar patterns to control Tg-5xFAD mice, however, RF-EMF exposure in Tg- 5xFAD mice showed opposite expression patterns. These findings indicate that chronic RF-EMF exposure directly affects Aβ pathology in AD but not in normal brain. Therefore, RF-EMF has preventive effects against AD-like pathology in advanced AD mice with a high expression of Aβ, which suggests that RF-EMF can have a beneficial influence on AD.
AI evidence extraction
Main findings
Tg-5xFAD and wild type mice were chronically exposed to 1950 MHz RF-EMF (SAR 5 W/kg) for 8 months. In Tg-5xFAD mice, exposure significantly reduced Aβ plaques, APP and APP-CTFs in whole brain (including hippocampus and entorhinal cortex), reduced the hippocampal Aβ42/Aβ40 ratio, inhibited BACE1 expression and neuroinflammation, and rescued memory impairment. Gene profiling indicated five Aβ-related genes were significantly altered in Tg-5xFAD mice with different response patterns in WT versus Tg-5xFAD following exposure.
Outcomes measured
- Aβ plaques
- APP and APP carboxyl-terminal fragments (CTFs)
- Hippocampal Aβ42/Aβ40 ratio
- BACE1 expression
- Neuroinflammation
- Memory impairment/behavior
- Hippocampal gene expression (microarray
- Tshz2
- Gm12695
- St3gal1
- Isx
- Tll1)
Limitations
- Sample size not reported in abstract
- Exposure source/setup (e.g.
- device/field characteristics beyond frequency and SAR) not described in abstract
- Findings are from an animal model
- relevance to humans not addressed in abstract
View raw extracted JSON
{
"study_type": "animal",
"exposure": {
"band": "RF",
"source": null,
"frequency_mhz": 1950,
"sar_wkg": 5,
"duration": "8 months; 2 hrs/day, 5 days/week"
},
"population": "Tg-5xFAD transgenic mice (Alzheimer’s disease model) and wild type mice",
"sample_size": null,
"outcomes": [
"Aβ plaques",
"APP and APP carboxyl-terminal fragments (CTFs)",
"Hippocampal Aβ42/Aβ40 ratio",
"BACE1 expression",
"Neuroinflammation",
"Memory impairment/behavior",
"Hippocampal gene expression (microarray; Tshz2, Gm12695, St3gal1, Isx, Tll1)"
],
"main_findings": "Tg-5xFAD and wild type mice were chronically exposed to 1950 MHz RF-EMF (SAR 5 W/kg) for 8 months. In Tg-5xFAD mice, exposure significantly reduced Aβ plaques, APP and APP-CTFs in whole brain (including hippocampus and entorhinal cortex), reduced the hippocampal Aβ42/Aβ40 ratio, inhibited BACE1 expression and neuroinflammation, and rescued memory impairment. Gene profiling indicated five Aβ-related genes were significantly altered in Tg-5xFAD mice with different response patterns in WT versus Tg-5xFAD following exposure.",
"effect_direction": "benefit",
"limitations": [
"Sample size not reported in abstract",
"Exposure source/setup (e.g., device/field characteristics beyond frequency and SAR) not described in abstract",
"Findings are from an animal model; relevance to humans not addressed in abstract"
],
"evidence_strength": "low",
"confidence": 0.78,
"peer_reviewed_likely": "yes",
"keywords": [
"radiofrequency electromagnetic fields",
"RF-EMF",
"1950 MHz",
"SAR 5 W/kg",
"Alzheimer's disease",
"Tg-5xFAD",
"amyloid beta",
"Aβ plaques",
"APP",
"BACE1",
"neuroinflammation",
"memory",
"microarray"
],
"suggested_hubs": []
}AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.
NNEMF synthesis
Synthesis pending.